F07 Indications and Evidence for Neuromodulation
3:30 PM - 5:00 PM Friday, July 16
This session is designed for residents and fellows. It will address several unique aspects of neuromodulation. It will focus on the use of neuromodulation specific for headaches. In addition, it will focus on the role of IDDS as well as PNS as analgesic therapies.
CME Credits: 1.5 AMA PRA Category 1 CreditsTM
Upon completion of this educational activity, participants should be able to:
- Discuss indications of neuromodulation for headaches.
- Describe an evidence-based approach to IDDS trials, including the NACC guidelines.
- Explain the evidence supporting peripheral nerve stimulation as an analgesic therapy.
Timothy R. Lubenow, MD
Preet Patel, MD
Neuromodulation for Headache
Samer Narouze, MD, PhD
Indications for SCS and PNS
David Spinner, DO
Programming: What Do I Need to Know?
Ellen L. Air, MD, PhD
Pumps: Let's Talk About Trials
Tammy L. Dann, DO,MPH
Faculty and Presentations subject to change.
- Walt Disney World Swan & Dolphin Resort